Ken Paxton Sues 3M and DuPont Over Dangerous ‘Forever Chemicals’

 

AUSTIN, TX Texas Attorney General Ken Paxton has filed a lawsuit against 3M and DuPont, the largest manufacturers of per- and polyfluoroalkyl substances (PFAS) chemical products, for misrepresenting the safety of brand names such as Teflon, Stainmaster, and Scotchgard in their advertising.

PFAS are called "forever chemicals" because they don’t break down in the environment and can build up in humans, animals, and water sources over time.

PFAS chemicals are linked to serious health problems, including cancer and thyroid disease. According to the lawsuit, despite knowing about the dangers for over 50 years, 3M and DuPont continued to advertise their products as "safe for everyday use."

The filing claims the companies marketed these products for over 70 years without telling the public about the risks.

“These companies knew for decades that PFAS chemicals could harm people’s health but kept promoting them as safe to use in homes, around children, and families,” said Attorney General Paxton.

“Texas is taking action to hold these companies responsible for deceiving people and putting Texans at risk.”

This lawsuit is part of Paxton’s efforts to hold companies accountable for the harmful effects of PFAS. Texas had already sued over another PFAS-containing product called Aqueous Film Forming Foam (AFFF) because it was damaging Texas' land and water.

For more details, you can read the full filing here.

Subscribe to the LIVE! Daily

The LIVE! Daily is the "newspaper to your email" for San Angelo. Each content-packed edition has weather, the popular Top of the Email opinion and rumor mill column, news around the state of Texas, news around west Texas, the latest news stories from San Angelo LIVE!, events, and the most recent obituaries. The bottom of the email contains the most recent rants and comments. The LIVE! daily is emailed 5 days per week. On Sundays, subscribers receive the West Texas Real Estate LIVE! email.

Required

Most Recent Videos

Post a comment to this article here: